BIOSTEM TECHNOLOGIES

BioStem Technologies develops, manufactures, and commercializes perinatal tissue-based allografts in the medical technology sector. The company offers...

BIOSTEM TECHNOLOGIES

BioStem Technologies develops, manufactures, and commercializes perinatal tissue-based allografts in the medical technology sector. The company offers allografts such as VENDAJE, VENDAJE AC, and VENDAJE OPTIC for regenerative therapies and wound care. BioStem Technologies was founded in 2006 and is based in Pompano Beach, Florida, previously known as Caribbean International Holdings.

Website

biostemtechnologies.com

General information

Firm type

Unclassified

Who runs BIOSTEM TECHNOLOGIES?

No principals, founders, or officers are publicly associated with BIOSTEM TECHNOLOGIES. Searches across state business registries, SEC filings, FINRA records, and professional networks including LinkedIn did not return any individuals linked to the firm in an official capacity.

Does BIOSTEM TECHNOLOGIES have any known funding or institutional backing?

No funding rounds, venture capital participation, or institutional investment has been reported for BIOSTEM TECHNOLOGIES.

Where is BIOSTEM TECHNOLOGIES headquartered?

No physical address or headquarters location has been identified for BIOSTEM TECHNOLOGIES. The firm has no known website, no LinkedIn company page, and is not listed in commercial real estate databases or Secretary of State business filings under this name.

Is BIOSTEM TECHNOLOGIES a publicly traded entity?

No. BIOSTEM TECHNOLOGIES does not trade on any public exchange, holds no SEC-registered securities, and has not filed for an initial public offering. It has no stock ticker, no market capitalization, and no analyst coverage.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Aug 10, 2026. Continuous refresh with full update cycles at least every 30 days.